T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.26% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Norwegian Cruise Line
NCLH
$8.98B
| $83.1M | 0.01% |
7,583,764
-10,042,619
| -57% | -$404M |
|
627
SouthState Bank Corp
SSB
$10.8B
| $83M | 0.01% |
1,413,512
-11,188
| -0.8% | -$827K |
|
628
US Physical Therapy
USPH
$1.24B
| $82.7M | 0.01% |
1,198,068
+201,138
| +20% | +$21.2M |
|
629
FB Financial Corp
FBK
$3.1B
| $82.7M | 0.01% |
4,191,920
+237,022
| +6% | +$7.59M |
|
630
Endava
DAVA
$167M
| $82.3M | 0.01% |
2,341,275
+268,559
| +13% | +$12.2M |
|
|
K
631
DELISTED
Kellanova
K
| $82.3M | 0.01% |
1,460,736
-105,078
| -7% | -$6.44M |
|
|
MLNX
632
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $82.2M | 0.01% |
677,651
-6,089
| -0.9% | -$716K |
|
633
Uber
UBER
$155B
| $81.9M | 0.01% |
2,932,348
-8,457,707
| -74% | -$278M |
|
634
Acadia Realty Trust
AKR
$2.86B
| $81.6M | 0.01% |
6,584,426
+33,742
| +0.5% | +$762K |
|
635
Flowserve
FLS
$10.3B
| $81.2M | 0.01% |
3,399,467
-2,577,644
| -43% | -$104M |
|
636
MKS Inc
MKSI
$20.7B
| $81.2M | 0.01% |
996,397
-70,315
| -7% | -$7.2M |
|
637
Scholastic
SCHL
$784M
| $80.7M | 0.01% |
3,166,815
+730,229
| +30% | +$23.7M |
|
638
Marathon Petroleum
MPC
$100B
| $80.3M | 0.01% |
3,400,793
-1,910,819
| -36% | -$88M |
|
639
Edwards Lifesciences
EW
$53.4B
| $80.3M | 0.01% |
1,277,292
+105,894
| +9% | +$7.64M |
|
640
Service Corp International
SCI
$11.3B
| $80.1M | 0.01% |
2,048,643
-28,438
| -1% | -$1.32M |
|
641
Healthcare Realty
HR
$6.58B
| $80M | 0.01% |
3,293,668
-1,167,403
| -26% | -$35.3M |
|
642
LCI Industries
LCII
$2.6B
| $79.9M | 0.01% |
1,195,671
+34,597
| +3% | +$3.37M |
|
643
McGrath RentCorp
MGRC
$2.94B
| $79.7M | 0.01% |
1,521,243
+131,639
| +9% | +$9.25M |
|
644
Compañía de Minas Buenaventura
BVN
$8.55B
| $78.9M | 0.01% |
10,828,894
+4,006,184
| +59% | +$45.6M |
|
645
Molson Coors Class B
TAP
$7.85B
| $78.3M | 0.01% |
2,006,655
+1,333,937
| +198% | +$67.6M |
|
646
Houlihan Lokey
HLI
$9.24B
| $78.3M | 0.01% |
1,501,767
-9,575
| -0.6% | -$496K |
|
647
Exponent
EXPO
$3.24B
| $78.2M | 0.01% |
1,087,756
-9,297
| -0.8% | -$675K |
|
648
CTS Corp
CTS
$1.79B
| $77.7M | 0.01% |
3,122,088
+232,398
| +8% | +$6.32M |
|
|
BNY
649
Bank of New York Mellon
BNY
$110B
| $77.3M | 0.01% |
2,293,687
-1,249,784
| -35% | -$52.5M |
|
|
NUVA
650
DELISTED
NuVasive, Inc.
NUVA
| $77.2M | 0.01% |
1,523,978
-105,872
| -6% | -$7.1M |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.